MoBiTec Launches SpeedBlot (His) – A Strikingly Fast and Easy-To-Use Western Blot Stain for His-Tagged Proteins

Instant detection of poly-histidine tagged proteins on nitrocellulose membrane with SpeedBlot (His) is easy and does not require relevant hands-on time. Even 0.1 pmol detection limits can be achieved with this highly sensitive detection reagent. While common Western Blot protocols require 6 to 21 hours, staining with SpeedBlot (His) is completed after just about 90 minutes. - June 12, 2014 - MoBiTec GmbH

Discover the Next IDE Inhibitor with the Newly Launched SensoLyte® IDE Activity Assay

AnaSpec Launches Industry’s First FRET-based Assay for Measurement of Insulin Degrading Enzyme (IDE) Activity for inhibitor high throughput screening- the SensoLyte® 520 IDE Activity Assay Kit. - June 12, 2014 - AnaSpec, EGT Group

IonSense Introduces the DART®-EDU Program to Provide Educational Institutions with an Economical Path to Ownership of Its State-of-the-Art Mass Spectrometry Technology

Educational Leasing Program will enable chemistry departments to lower operating costs while providing students access to Direct Analysis in Real Time Mass Spectrometry. To be exhibited at the 62nd ASMS Conference on Mass Spectrometry and Allied Topics in Baltimore, MD, June 15-19, 2014, Booth 120. - June 10, 2014 - IonSense, Inc.

Women’s Health: Dr. Kathy Maupin Announces a Free Webinar to Answer Questions About Hormone Replacement

Hormone expert will answer questions about treatment for symptoms of menopause and testosterone deficiency through bioidentical hormone replacement therapy. - June 08, 2014 - BioBalance Health

AveXis to Present at Families of Spinal Muscular Atrophy Annual Conference

AveXis, a clinical stage synthetic biology platform company, today announced that Dr. Allan Kaspar, Chief Scientific Officer, will be presenting at The Family and Researcher Poster Session at The Annual Spinal Muscular Atrophy Conference, which will be held on Thursday, June 12, 2014 in National... - June 08, 2014 - AveXis Inc.

Recursion Pharmaceuticals Announces Dr. H. Perry Fell as the First Member of Business Advisory Panel

Recursion Pharmaceuticals, a biotech start-up in Salt Lake City today announced the formation of its Business Advisory Panel. The first appointment to the Advisory Panel is H. Perry Fell, MBA, Ph.D. Perry is a distinguished scientist and leader who most prominently co-founded Seattle Genetics (NASDAQ: SGEN) and served as its CEO from start-up through IPO. - June 05, 2014 - Recursion Pharmaceuticals

ACT Enters Phase I Human Clinical Trials with First-in-Class Anti-Cancer Drug Candidate

Advanced Cancer Therapeutics (ACT), a privately held company dedicated to bringing new anti-cancer therapies to market, announced today that it has begun clinical trials of PFK-158, a small molecule therapeutic candidate that inactivates a novel cancer metabolism target never before examined in... - June 04, 2014 - Advanced Cancer Therapeutics

Colorado BioScience Association Praises Boettcher Foundation as It Embarks on the Fifth Year of Its Webb-Waring Biomedical Research Program

Colorado BioScience Association congratulates Boettcher Foundation on the announcement of its 2014 class of Boettcher Investigators in the Webb-Waring Biomedical Research Program. Starting its fifth year, the program provides for the discovery of new knowledge that improves human health through the investment in and advancement of early-career scientists. - June 03, 2014 - Colorado BioScience Association

Well-Known Denver Real Estate Developer John M. Shaw to Oversee Properties in the Colorado Life Science District at Fitzsimons

Fitzsimons Redevelopment Authority (FRA) is partnering with John M. Shaw as a consultant to oversee its real estate projects in the Colorado Life Science District at Fitzsimons. Shaw’s extensive track record of successful real estate development projects makes him the ideal partner to continue the FRA’s vision to build a world class life science district at Fitzsimons. - May 30, 2014 - Fitzsimons Redevelopment Authority

Bioo Scientific Receives Presidential Award for Exports

U.S. Secretary of Commerce Penny Pritzker today presented Bioo Scientific with the President’s “E” Award for Exports at a ceremony in Washington, D.C. The “E” Awards are the highest recognition any U.S. entity may receive for making a significant contribution to the... - May 30, 2014 - Bioo Scientific

Solvo Biotechnology, the Transporter Company and Qualyst Transporter Solutions Execute a License to B-Clear® Services

Agreement Supporting Use of Qualyst’ s Patented B-CLEAR® Technology for Services offered by Solvo Biotechnology - May 29, 2014 - Solvo Biotechnology

Industry's First Fluorimetric Assay for Glutaminyl Cyclase

AnaSpec Launches Industry’s First Fluorimetric, 96-well format Assay for Measurement of Glutaminyl Cyclase (QC) Activity - the SensoLyte® Green Glutaminyl Cyclase Activity Assay Kit. - May 29, 2014 - AnaSpec, EGT Group

Life Science Strategy Group Launches the OutsourcePharma Advisory Board

Online community dedicated to pharmaceutical sponsors provides open forum to discuss drug development and outsourced Contract Research Organization (CRO) services. - May 28, 2014 - Life Science Strategy Group, LLC

MiTeGen Awarded $998K NIH Phase II SBIR Grant to Develop Hyperquenching Devices

Two year funding for the development of advanced cooling devices. - May 24, 2014 - MiTeGen, LLC

Disposable Transfer Pipette Promotion Now Available at Leading Distributor Pipette.com

Disposable transfer pipette promotion now available at major pipette distributor, Pipette.com. Research labs doing chemistry, basic biology, and/or any other type of liquid handling analysis will find this promotion beneficial. - May 24, 2014 - Pipette.com

Jane Rohlf, MD & Premier Research Join Wake Research: New Investigational Site Added to Established Organization of Integrated Clinical Research Investigational Site

Raleigh-based Wake Research (Wake Research Associates, L.L.C.) announces an affiliation with Dr. Jane Rohlf and Premier Research, of Trenton, New Jersey. “Dr. Rohlf brings wealth of research expertise and her site fit well into our strategic plan to offer Biopharmaceutical Industry a broad... - May 24, 2014 - Wake Research Associates

Bioo Scientific Offers State-of the-Art, Full Service Analytical Food Testing

Bioo Scientific is offering testing services for antibiotic, toxin, hormone and pathogen contamination in food and feed. These services provide testing capabilities to food and feed producers without laboratory infrastructure. - May 23, 2014 - Bioo Scientific

endpoint Introduces PULSE™ 3.0 Platform for IRT Systems in Clinical Trials

PULSE enables highly customized IRT trial design while maintaining endpoint’s signature 30-Day delivery timeline. - May 23, 2014 - endpoint

Northeastern M.D.s to Gather for Presentation by Dr. Emil J. Haldey, Leading Pharmaceutical Compounding Expert

Northeastern M.D.s to Gather for Presentation by Dr. Emil J. Haldey, Leading Pharmaceutical Compounding Expert

The prestigious National Medical Association will host a seminar on Friday featuring Dr. Emil J. Haldey, a doctor of pharmacy and a leader in the specialized field of pharmaceutical compounding. The event will take place May 23, beginning at 2 p.m., during the National Medical Association Annual... - May 22, 2014 - HALDEY Pharmaceutical Compounding

Pipette.com, Major Pipette Distributor, Launches Twitter Art Contest

Pipette.com is giving away a brand new pipette as well as other lab prizes to a lucky Twitter follower. In addition, followers may now enter to win other prizes including free pipette-themed shirts, discounted calibration, and more. - May 22, 2014 - Pipette.com

AveXis Announces Opening of Enrollment for Gene Transfer Clinical Trial for Spinal Muscular Atrophy Type 1 at Nationwide Children's Hospital

AveXis, Inc., a clinic-ready synthetic biology platform company, today announced that the Gene Transfer Clinical Trial for Spinal Muscular Atrophy Type 1 has now formally begun enrollment at Nationwide Children’s Hospital. This trial will utilize chariSMA, the gene therapy product developed... - May 16, 2014 - AveXis Inc.

MiTeGen Announces Collaboration and License Agreements with MagnebotiX and NatX-ray

MiTeGen LLC, a provider of innovative consumables for X-ray diffraction, crystallography and protein crystallization to academic, pharmaceutical, industrial and government researchers around the world, announced that it has signed agreements with MagnebotiX AG, and with NatX-ray SAS, and NatX-ray LLC for the development and distribution of RodBot non-contact magnetic rolling sample manipulation technology for crystallization and crystal handling. - May 14, 2014 - MiTeGen, LLC

VIRUN NutraBIOsciences™, Leader in Cognitive-Functional-Ingredients, to Sponsor Cognitive Health Forum at NutraIngredients-USA

VIRUN NutraBIOsciences™, Leader in Cognitive-Functional-Ingredients, to Sponsor Cognitive Health Forum at NutraIngredients-USA

VIRUN, leader in Cognitive health ingredients, is sponsoring NutraIngreidents Cognitive Health Forum on May 22nd, 2014. According to NutraIngredients-USA, “Industry leaders from companies such as Abbott Nutrition, Standard Process, Nawgan, and Euromonitor will join for a discussion of the cognitive health sector, from science and claim substantiation, to market sizing and key consumer demographics.” - May 13, 2014 - VIRUN

Social & Scientific Systems Wins Healthcare Data Analytics and Statistical Products Contract

Social & Scientific Systems, Inc. (SSS), a public health research services provider, has announced that it was recently awarded a health care data analytics and statistical products contract with the Agency for Healthcare Research and Quality (AHRQ). The contract, which is expected to continue... - May 11, 2014 - Social & Scientific Systems, Inc.

Colorado BioScience Association Announces Two New Directors at Annual All-Member Meeting

Colorado BioScience Association (CBSA) announced two new board members at its 2014 Annual All-Member meeting held at the Omni Interlocken Resort, Broomfield, CO. Also on the agenda, CBSA recognized both its 2014 Corporate Sponsors and 10-year members at the annual meeting. - May 09, 2014 - Colorado BioScience Association

MoBiTec GmbH to Attend the International Conference on Stem Cell and Tissue Formation in Dresden, Germany, from July 8-11, 2014

For the 5th time, Stem Cell researchers will convene for the International Conference on Stem Cell and Tissue Formation in Dresden, Germany. At MoBiTec's booth high quality products as well as cutting-edge technologies will be presented. - May 09, 2014 - MoBiTec GmbH

Xcelthera Secures Patent for Large-Scale Production High Quality Human ES Cell Therapy Products

Xcelthera Inc and its joint research partner San Diego Regenerative Medicine Institute announced today that the USPTO has granted Patent No. 8,716,017 entitled “Technologies, Methods, and Products of Small Molecule-Directed Tissue and Organ Regeneration from Human Pluripotent Stem Cells”. - May 08, 2014 - Xcelthera Inc

MoBiTec GmbH, Germany, Issues New Fluorescent Probes Brochure, Ready for Free Download as PDF

A brochure featuring Fluorescent Probes for Protein and Nucleic Acid Labeling provided by MoBiTec as Free PDF Download. - May 08, 2014 - MoBiTec GmbH

Eppendorf Reference 2 Trade in Program and Eppendorf Starter Kit Specials Now Available at Major Pipette Distributor Pipette.com

Pipette.com has announced the Eppendorf Reference 2 Trade-In Program which allows lab technicians to trade in any of their old pipettes for credit towards a brand new Eppendorf Reference 2 pipette. Clinical and reference labs are the ideal users for these pipettes. - May 04, 2014 - Pipette.com

Solanbridge Group Inc. Announces Appointment of Dr. Mark T. Cullen

Solanbridge Group (SLNX) has hired Dr. Mark Cullen to develop CBD-enfused products for the State of Nevada. - May 02, 2014 - Solanbridge Group Inc

Colorado BioScience Association Names Logan Collins, Fairview High School Junior, as Colorado’s BioGENEius Finalist

Logan Collins Advances to San Diego to Compete Against Top Students from Across the Nation and Canada. - May 02, 2014 - Colorado BioScience Association

Dr. Tovia Martirosian Smith Joins Virginia Women’s Center’s Pelvic Health and Continence Institute

The seven-location OB-GYN practice welcomes Richmond-native Dr. Tovia Martirosian Smith to the recently formed Pelvic Health and Continence Institute. - May 01, 2014 - Virginia Women's Center

Major Pipette Distributor Pipette.com Has Announced Their Biohit Picus Trade in Program

Pipette.com has announced their Biohit Picus Trade In Program which will benefit labs looking for a high quality electronic pipette to be used as a general purpose liquid handling instrument. - May 01, 2014 - Pipette.com

NanoAxis Aligns with NanoApps Medical Inc. to Accelerate Commercial Novel Nanomedicine Diagnostic and Pharmaceutical Product Development

NanoAxis LLC has announced that it has become a shareholder in Canadian based company, NanoApps Medical Inc., to assist in accelerating nanomedical product development and commercialization. NanoApps Medical Inc. is actively collaborating with both Canadian and US based (Mayo Clinic, Rochester,... - April 26, 2014 - NanoAxis

BiologicsCorp Launches Supernatant Protein Expression Service

BiologicsCorp Launches Supernatant Protein Expression Service

BiologicsCorp proudly launches this new service - another first in the industry. They have tested many variables, including codon optimization, strain, charperones and foldases, and others. Give Supernatant Service a try, especially if your protein of interest could not be expressed in soluble form. BiologicsCorp is confident and can guarantee success - no soluble fraction for target protein, no payment for expression service. - April 25, 2014 - BiologicsCorp

AveXis Closes a Round of Financing from PBM Capital to Advance Its SMA Gene Therapy Program

AveXis, Inc., a clinic-ready synthetic biology platform company, today announced it has completed a financing round led by PBM Capital Group. This round of financing will help support the company’s gene therapy program targeting spinal muscular atrophy (SMA). AveXis’ gene therapy... - April 23, 2014 - AveXis Inc.

Epitope Diagnostics, Inc. Expands Product Panel with New Set of H. Pylori Antigen ELISA Kits and Novel Sample Collection Device

Epitope Diagnostics, Inc. has launched two user-friendly fecal Helicobacter pylori (H. pylori) antigen ELISA kits, along with a new sample collection device. One ELISA assay is qualitative while the other is quantitative, allowing for both the detection and measurement of active H. pylori antigen. H. pylori is a bacterium which causes infectious stomach disease and is linked to stomach cancer. A positive H. pylori antigen test indicates an active infection. - April 22, 2014 - Epitope Diagnostics, Inc.

Women Found to be at Greater Risk for Alzheimer’s - Find Solution with MentScan from MMT

Women with Alzheimer’s Gene fight back with MMT’s screening test called the MentScan. - April 18, 2014 - MD Stem Cells

MD Stem Cells Names Top 7 Recent Stem Cell Advances

7 key advances in Stem Cell treatments and research identified by MD Stem Cells. - April 17, 2014 - MD Stem Cells

Recursion Pharmaceuticals Announces Formation of Its Scientific and Technical Advisory Board

Recursion Pharmaceuticals is a start-up biotech firm in Salt Lake City with a goal of discovering new therapeutics for the treatment of rare genetic diseases. Recursion announced the formation of its Scientific and Technical Advisory Board today, along with the appointment of Dr. Anne Carpenter and Dr. Kirk Thomas as its first two members. - April 12, 2014 - Recursion Pharmaceuticals

Registration Now Open at CBSA Website: GoldLab 5th Annual Symposium 2014, “Embracing the Reptile Within: Head, Heart and Healthcare”

Registration is now open at the CBSA website for the fifth annual GoldLab Symposium, taking place on the University of Colorado Boulder campus, Friday and Saturday, May 16 - 17, 2014. This year’s Symposium, entitled “Embracing the Reptile Within: Head, Heart and Healthcare” brings together 18 renowned scientists and healthcare experts to discuss progress and issues in personalized medicine. - April 11, 2014 - Colorado BioScience Association

MOgene LC Announces Addition of Illumina NextSeq 500 Service

MOgene LC, an Illumina CSPro™ certified service provider, announced today that they have added Illumina NextSeq 500 to their list of services. Illumina NextSeq 500 performs whole-genome, exome, and transcriptome sequencing and is flexible, offering tunable read length and multiple output... - April 08, 2014 - MOgene, LC

Dr. Kristy Ainslie Strengthens Drug Delivery Focus as She Becomes Advisor to Peptineo

Peptineo is pleased to welcome Dr. Ainslie to advisory board at Peptineo. Dr. Ainslie received her PhD in Chemical Engineering from Penn State, and after a short post doc in a start up company focused on biosensor development, Protiveris, she completed a post doc at UCSF. During her post doc, she... - April 08, 2014 - Peptineo

Dr. Applegate to Join Advisory Board at Peptineo

Peptineo is pleased to welcome Dr. Robert Applegate to the advisory board of Peptineo. Dr. Applegate is a recognized expert in microfluidics, biomedical devices and optical technologies. As a result of his research, Dr. Applegate holds patents in optical trapping, cell diagnostics and sorting, and... - April 07, 2014 - Peptineo

Bioo Scientific Launches Re-usable Cost-Effective AflaPure™ Aflatoxin Affinity Columns

Bioo Scientific’s AflaPure™ Alfatoxin Total and AflaPure™ Aflatoxin M1 Column Kits are the first commercial immunoaffinity columns for aflatoxin enrichment designed to reduce cost of lab consumables by allowing regeneration between uses. The AflaPure columns can be used up to... - April 05, 2014 - Bioo Scientific

ALPCO Expands EuroFlow™ Product Offering with the Addition of Plasma Cell Dyscrasias Screening Tube

ALPCO Expands EuroFlow™ Product Offering with the Addition of Plasma Cell Dyscrasias Screening Tube

ALPCO has expanded EuroFlow™ product offering with addition of the Plasma Cell Screening Tube from Cytognos S.L. - April 03, 2014 - ALPCO

Peptineo, a Biotechnology Company Focused on Value Recovery in Pharma, Announces the Appointment of Kamal Garcha PhD., to Advisory Board

"We welcome the addition of Dr. Garcha," noted Sheldon K. Jordan, PhD, CEO. Dr. Garcha holds an Honor’s BSC in Cell Biology and MSc. in Zoology from Western University, and a PhD. in Cellular & Physiological Sciences from the University of British Columbia. During the course of... - April 02, 2014 - Peptineo

OsoBio Appoints Catherine Buck Director of Manufacturing

Buck has 20-plus years of experience managing pharma and commercial manufacturing plants. - April 02, 2014 - OSO BioPharmaceuticals Manufacturing, LLC

Peptineo Adds Dr. Yoganathan to Advisory Board to Strengthen Biomaterials Development and Commercialization

Dr. Yoganathan is a SME in the areas of biomaterials and drug delivery - having collaborated and worked closely with thought-leaders in the field such as Dr. Robert Langer, Dr. Kazunori Kataoka, Dr. Michael V. Sefton and Dr. Christine Allen. He is an expert in manipulating material properties to... - March 31, 2014 - Peptineo

Revolutionary Science Teaching Model Transforms Diabetes HbA1c Blood Test Into Hand-Held Education

Biologic Designs launches first crowdfunding campaign to introduce its latest educational product, the Glycated Hemoglobin A1c (HbA1c) Teaching Model. The biologic protein marker from the HbA1c blood test is no longer just a number; it is a physiological process that can be demonstrated to patients through tactile science education. - March 29, 2014 - Biologic Designs LLC

Press Releases 1,251 - 1,300 of 3,209